Esatam, Dionesa .

HRN: 14-85-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2024
AMPICILLIN 1GM (VIAL)
12/08/2024
12/11/2024
IVT
2g
Q6
Prom
Waiting Final Action 
12/08/2024
CEFUROXIME 500MG (TAB)
12/08/2024
12/14/2024
ORAL
500mg
BID
PROM X 14 Hours
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: